SPECTRUM OF ANTIBIOTIC SUSCEPTIBILITY PATTERN IN EXTENDED SPECTRUM BETA LACTAMASE (ESBL) PRODUCING ESCHERICHIA COLI IN CASE OF URINARY TRACT INFECTION IN TERTIARY MEDICAL CENTRE.

Dr. Ashis Kumar Saha

Abstract


Background: In India females are most vulnerable to both community acquired and hospital acquired urinary tract infection caused by Escherichia coli. Due to improper use of antibiotics there is emergence of multidrug-resistant ESBL producing E coli as a result mortality and morbidity of the patient are increased. Aims & Objectives: Aim of this study was to show the pattern of antibiotic susceptibility and thus resistance to different types of antibiotics against ESBL producing Escherichia coli induced urinary tract infection so that proper antibiotic can be prescribed and to know the which antibiotic should be prescribed in the local geographical area to treat urinary tract infection. Materials and method: Midstream morning clean-catch urine from the patients was sent to the nearest laboratory for culture and sensitivity without delay. After culture of the organism ESBL production was detected followed by testing of antibiotic sensitivity. Results: Urine samples from 348 patients (out of total 1800 samples, 800 males and 1000 females) demonstrated highest sensitivity to carbapenam group and nitrofurantoin, moderate sensitivity to netilmicin, amikacin, piperacillin-tazobactum, polymyxin B and colistin but highly resistant to ampicillin, chloramphenicol, ticarcillin, fairly resistant to ofloxacin group of drugs except levofloxacin, 4th generation cephalosporin. Conclusion: Progressively increasing resistance to common antibiotics against ESBL producing Escherichia coli due to unnecessary, inadvertent and over the counter use of antibiotics warn the internist to use antibiotics only after getting the result of culture-sensitivity of urine from the laboratory.


Keywords


ESBL producing E Coli, Urinary tract infection, Antibiotic susceptibility, Tertiary Medical Centre

Full Text:

PDF

References


Mehta M et al. Prevalence and antibiotic susceptibility pattern of multi-drug resistant Escherichia coli isolates from urinary tract infection (UTI) pattern. Int J Life Sci Pharm Res. 2012; 6:2

Gerasimovska V, Gerasimovska-Kitanovska B. Extended spectrum beta-lactamase (ESBL) strains of E. coli as a cause of urinary tract infections in hospitalized patients. Antimicrobial Resistance and Infection Control. 2015; 4:P121.

Noor N et al. Urinary tract infections associated with multi-drug resistant enteric bacilli: characterization and genetical studies. Pak J Pharm Sci. 2004; 17:115.

Dehbanipour R et al. High prevalence of multi-drug resistance uropathogenic Escherichia coli strains, Isfahan, Iran. Jou. rnal of Natural Science, Biology And Medicine. 2016; 7:22.

Jan N et al. Plasmid profile analysis of multi-drug resistant E. coli isolated from UTI patients of Nagpur City, India. Romanian Biotechnological letters. 2009; 14:4635.

Ghafourian S et al. Incidence of extended spectrum beta lactamase producing Klebsiella pneumoniae in patients with urinary tract infection. Sao Paulo Medical Journal. 2012; 130:37.

Bradford PA. Extended spectrum beta-lactamase in the 21st century: characterization, epidemiology and detection of this important resistance threat. Clin Microbiol Rev [Internet]. 2001; 14(4):933-951.

All AM, Rafi S, Qureshi AH. Frequency of extended spectrum beta-lactamase producing gram-negative bacilli among clinical isolates at clinical laboratories of Army Medical College. Rawalpindi. Ayub Med Cell Abbottabad. 2004; 16:35-37.

Sharma M, Pathak S, Srivastava P. Prevalence and antibiogram of Extended Spectrum Beta-lactamase (ESBL) producing gram negative bacilli and further molecular characterization of ESBL producing Escherichia coli and Klebsiella soo. J Clin Diagn Res. 2013; 7:2173-2177.

Ruppe E, Wqerther PL, Barbier F. Mechanisms of antimicrobial resistance in gram negative bacilli. Ann Intensive Care. 2015; 5:61.

Jesus RB, Paterson PL. Changes in Epidemiology of infections due to Extended-Spectrum β-Lactamase – Producing Organisms. Clin Infect Dis. 2006; 42(7):935-937.

Coldner R, Rock W, Chazan B, Keller N, Guy N, Sakran W, Raz R. Risk factors for the department of Extended Spectrum Beta-lactamase Producing Bacteria in Non-hospitalised Patients. Eur J Clin Microbiol Infect Dis. 2004; 23(3):163-167.

Tille P, Chiana:Elsevir Health Sciences. 2013; Bailey & Scott’s Diagnostic Microbiology.

Bader MS et al. An update on the management of urinary tract infections in the era of antimicrobial resistance. Postgraduate Medicine. 2017; 129:242.

Azap O et al. Risk factors for extended-spectrum β-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clinical Microbiology and Infection. 2010; 16:147.

Shiva Hashemi et al. Irrational antibiotic prescribing: a local issue or global concern? Excli Journal. 2013; 12:384.

Gonzalez-Padilla M, Torre-Cisneros J, Rivera-Espinar F et al. Gentamicin therapy for sepsis due to carbapenem-resistant and colistin-resistant Klebsiella pneumonae. J Antimicrob Chemother. 2015; 70:905-913.

Perez F, Endimiani A, Hujer KM, Bonomo RA. The continuing challenge of ESBLs. Curr Opin Pharmacol. 2007; 7(5):459-469.

Shakya P et al. ESBL production among E coli and Klebsiella spp. Causing urinary tract infection: A hospital based study. The Open Microbiology Journal.2017; 11:23.

Moayednia R et al. Frequency assessment of β-lactamase enzymes in Escherichia coli and Klebsiella isolates in patients with urinary tract infection. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences. 2014; 19:S41.

Pourakbari B et al. Increase resistant rates and ESBL production between E coli isolates causing urinary tract infection in young patients from Iran. Brazilian Journal of microbiology. 2012; 43:766.

Akram M et al. Etiology and antibiotic resistance patterns of community acquired urinary tract infection in JNMC Hospital, Aligarh, India. Annals of Clinical Microbiology and Antimicrobials. 2007; 6:4.

Shiva Hasemi et al. Irrational antibiotic prescribing a local issue or global concern? Excli Journal. 2013; 12:384.

Hossein Khalili et al. Adherence to empirical antibiotic therapy guideline in a referral teaching hospital. Tehran, Iran. Acta Medica Iranica. 2020; 50:47.

Pouladfar G et al. The antibiotic susceptibility patters of uropathogens among children with urinary tract infections in Shiraz. Medicine. 2017.

Bahman H et al. Comparison of 3-day and 7-day ciprofloxacin regimen for the treatment of uncomplicated urinary tract infection in wo9men. A randomized double-blind clinical trial. Iranian Journal of clinical infection diseases. 2010; 5:70.

Sood S, Gupta R. Antibiotic resistance pattern of community acquired Uropathogens at a Tertiary care hospital in Jaipur, Rajasthan. Indian J Community Med. 2012; 37:39.

Nisel Yilmaz et al. Antimicrobial susceptibilities of Escherichia coli isolates as agents of community acquired urinary tract infection (2008 – 2014). Turk J Urol. 2016; 42:32.

Jin Ju Park et al. Antimicrobial susceptibilities of Enterobacteriaceae in community acquired urinary tract infectios during a 5-year period: A single Hospital study in Korea. Infect Chemother. 2017; 49:184.

Siegel JD, Rhinehart E, Jackson M, Chiarello L. Healthcare Infection control practices Advisory Committee management of multidrug-resistant organisms in health care3 settings, 2006. Am J Infect Control. 2007; 35(10):5165-5193.

Lye DC, Wijaya L, Chan J, Chew PT, Yee SL. Ertapenem for treatment of extended-spectrum beta-lactamase producing and multidrug-resistant gram-negative bacteremia. Ann Med Singapore. 2008; 37:831-834.


Refbacks

  • There are currently no refbacks.